SQZ Biotech

About:

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Website: http://sqzbiotech.com

Twitter/X: SQZBiotech

Top Investors: Temasek Holdings, Alumni Ventures, National Science Foundation, Invus, Google Ventures

Description:

SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

Total Funding Amount:

$230M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

admin(AT)sqzbiotech.com

Founders:

Armon Sharei, Klavs Jensen, Xing Zhao

Number of Employees:

101-250

Last Funding Date:

2022-03-21

IPO Status:

Public

Industries:

© 2025 bioDAO.ai